Innovation & Technology transfer
Four companies have been created since launch of the program.
![resilience](https://prism.center/wp-content/uploads/2022/11/resilience.jpg)
Resilience : a mobile application to better manage the disease.
ORAKL : development of functional in vitro diagnostic tests, “organograms”, to predict the responses of cancers to drugs.
![orakl](https://prism.center/wp-content/uploads/2022/11/orakl.jpg)
![cure51](https://prism.center/wp-content/uploads/2022/11/cure51.jpg)
Cure51 : learning from cancer survivors
Elikya Therapeutics : innovative molecules for cancer treatment.
![elikya](https://prism.center/wp-content/uploads/2022/11/elikya.jpg)
Prism is a one-of-a kind partnership between
![logoGR](https://prism.center/wp-content/uploads/2020/05/logoGR.png)
![LogoCS](https://prism.center/wp-content/uploads/2020/05/LogoCS.png)
![LogoUPS](https://prism.center/wp-content/uploads/2020/05/LogoUPS.jpg)
![unicancer](https://prism.center/wp-content/uploads/2022/06/unicancer.png)
![LogoInserm](https://prism.center/wp-content/uploads/2020/05/LogoInserm.png)
![PRISM_logo](https://prism.center/wp-content/uploads/2020/04/PRISM_logo.png)
![anr-logo-2021](https://prism.center/wp-content/uploads/2022/06/anr-logo-2021.png)
![france-2030-150x150](https://prism.center/wp-content/uploads/2022/06/france-2030-150x150-1.jpg)
![logo_pscc.png_page](https://prism.center/wp-content/uploads/2022/11/logo_pscc.png_page.png)
Label
Centre National de Médecine de Précision en Oncologie
Where to find us
Prism IHU-B
Bâtiment de médecine moléculaire
32 Rue Camille Desmoulins
94800 Villejuif
Tél. +33(0)1 42 11 00 00
info -at- prism.center
![map_b2m](https://prism.center/wp-content/uploads/2022/11/map_b2m.jpg)
Liens
Press
Work with us
Call for project
Accessibility
Cookies
Legal notice